ÁÖ¼±Çü ¸íÀÇ

°£, ½ÅÀå µ¿½Ã ÀÌ½Ä ¼º°øÇÑ Àå±â ÀÌ½Ä ½Ç·ÂÀÚ

ÁÖ¼±Çü ¸íÀÇ

  • ¼Ò ¼Ó
    °­µ¿°æÈñ´ëÇб³º´¿ø °£´ãÃé¿Ü°ú,¼ÒÈ­±â¿Ü°ú,À̽Ŀܰú
  • Àü¹®ºÐ¾ß
    °£¾Ï, ´ãµµ¾Ï, ÃéÀå¾Ï, ´ã¼®Áõ, °£À̽Ä, ½ÅÀåÀ̽Ä, º¹°­°æ¼ö¼ú, ·Îº¿¼ö¼ú

°£´ãÃé Áúȯ ¹× °£ÀÌ½Ä ºÐ¾ßÀÇ ½Ç·ÂÀÚ´Ù. ÁÖ¿ä Áø·á ºÐ¾ß´Â °£¾Ï, ´ãµµ¾Ï, ÃéÀå¾Ï, ´ã¼®Áõ, °£À̽Ä, ½ÅÀåÀ̽ÄÀ¸·Î ¿¬°£ 400·Ê ÀÌ»óÀÇ º¹°­°æ ´ã³¶ ÀýÁ¦¼ú°ú °£´ãÃé ¾Ç¼ºÁ¾¾ç ¼ö¼úÀ» ½ÃÇàÇϰí ÀÖ´Ù. °æÈñ´ëÇб³ ÃÖÃÊ·Î ¼ºÀÎ ´ë»ó ÀÌ½Ä »ç·Ê¿¡¼­, °£ Àüü°¡ ¾Æ´Ñ ÀϺθ¦ Á¦°ÅÇϰí ÀϺÎÀÇ °£À» À̽ÄÇÏ´Â ¡®µ¿¼Ò¼º ºÎºÐ º¸Á¶ °£ÀÌ½Ä ¼ö¼ú(Auxiliary partial orthotopic LT, APOLT)¡¯À» ¼º°øÀûÀ¸·Î ½ÃÇàÇß´Ù.
¶ÇÇÑ ÇѸíÀÇ ³ú»çÀÚ¿¡°Ô ±âÁõ¹ÞÀº °£°ú ½ÅÀåÀ» ´Ù¸¥ ÇѸíÀÇ È¯ÀÚ¿¡°Ô À̽ÄÇÏ´Â °£-½ÅÀå µ¿½ÃÀ̽ÄÀ» ¼º°øÇϱ⵵ Çß´Ù. ¿¬À̾î À̽ļö¼ú¿¡ ¼º°øÇϸ鼭 ³ú»çÆÇÁ¤ ´ë»óÀÚ °ü¸® Àü¹®±â°ü(HOPO)À¸·Î ÁöÁ¤µÇ´Â ¹ßÆÇÀ» ¸¶·ÃÇß´Ù. °£´ãÃé ¹× ÀÌ½ÄÆÄÆ®´Â ¿Ü°ú ¿µ¿ª¿¡¼­µµ ¸Å¿ì Àü¹®¼ºÀÌ ¿ä±¸µÇ´Â ¿µ¿ªÀ¸·Î º¹ÀâÇÏ°í ±ä ¼ö¼ú½Ã°£À¸·Î ¼ö¼ú¿¡ µû¸£´Â ºÎ´ãÀÌ Å©Áö¸¸, ÇÕº´ÁõÀÇ ÃÖ¼ÒÈ­ ¹× ¼ö¼ú ÈÄ È¯ÀÚÀÇ ¿øÈ°ÇÑ È¸º¹À» À§ÇØ ÃÖ¼±À» ´ÙÇϰí ÀÖ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • ¿ï»ê´ëÇб³ ¹Ú»ç
  • ¿ï»ê´ëÇб³ ¼®»ç
  • °æÈñ´ëÇб³ Çлç

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) °æÈñ´ëÇб³ Àǰú´ëÇÐ ±³¼ö
  • 2023~ 2024 °­µ¿°æÈñ´ëÇб³º´¿ø ½ÉÀÇÁ¶Á¤Ã³Àå
  • 2020~ 2023 °­µ¿°æÈñ´ëÇб³º´¿ø ±âȹÁø·áºÎ¿øÀå
  • 2017~ 2020 °­µ¿°æÈñ´ëÇб³º´¿ø ¼ö¼úºÎÀå
  • 2018~ 2020 °­µ¿°æÈñ´ëÇб³º´¿ø ·Îº¿¼ö¼ú¼¾ÅÍÀå
  • 2014~ 2018 °­µ¿°æÈñ´ëÇб³º´¿ø Àå±âÀ̽ļ¾ÅÍÀå
  • 2011~ 2018 °­µ¿°æÈñ´ëÇб³º´¿ø ¿Ü°úÀå
  • 2010~ 2011 Miami Transplant Institute Research Fellow
  • 2002~ 2006 ÇѸ²´ëÇб³ °­µ¿¼º½Éº´¿ø ¿Ü°ú ±³¼ö
  • 2000~ 2001 ¼­¿ï¾Æ»êº´¿ø °£ÀÌ½Ä °£´ãÃé ¿Ü°ú ÀüÀÓÀÇ
  • 1993~ 1997 ¼­¿ï¾Æ»êº´¿ø ¿Ü°ú Àü°øÀÇ

ÇÐȸȰµ¿

Academic activities
  • ´ëÇÑ ¿Ü°úÇÐȸ Á¤È¸¿ø
  • ´ëÇÑ À̽ÄÇÐȸ Á¤È¸¿ø
  • Çѱ¹°£´ãÃé ¿Ü°úÇÐȸ Á¤È¸¿ø
  • member of International society of liver surgeons
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 0°Ç
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ Complex Hypersensitivity and Irritation Reaction (CHAIR) Phenomenon after Cyanoacrylate Closure of Varicose Vein
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö Vascular Specialist International
Á¦ ¸ñ Successful non-surgical treatment for isolated right anterior section bile duct injury following laparoscopic cholecystectomy: Report of a case
¹ßÇ¥³âµµ 2022 ¹ßÇ¥Áö Annals of Liver Transplantation
Á¦ ¸ñ Non-Invasive Diagnosis for Acute Rejection Using Urinary mRNA Signature Reflecting Allograft Status in Kidney Transplantation
¹ßÇ¥³âµµ 2021 ¹ßÇ¥Áö FRONTIERS IN IMMUNOLOGY
Á¦ ¸ñ Protective Effect of Polydeoxyribonucleotide Against CCl4-Induced Acute Liver Injury in Mice
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö International Neurourology Journal
Á¦ ¸ñ Clinicopathologic analysis of intraductal papillary neoplasm of bile duct: Korean multicenter cohort study
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö HPB
Á¦ ¸ñ Predictor of abnormal gallbladder ejection fraction in patients with atypical biliary pain: Histopathological point of view
¹ßÇ¥³âµµ 2017 ¹ßÇ¥Áö Medicine (United States)
Á¦ ¸ñ Liver-Wrapping, Nitric Oxide-Releasing Nanofiber Downregulates Cleaved Caspase-3 and Bax Expression on Rat Hepatic Ischemia-Reperfusion Injury
¹ßÇ¥³âµµ 2017 ¹ßÇ¥Áö TRANSPLANTATION PROCEEDINGS

¸íÀÇqna ¸íÀÇ QnA

Q °¡Àå °ü½É ÀÖ´Â ºÐ¾ß¿Í ¾÷ÀûÀÌ ÀÖ´Ù¸é ¾Ë·ÁÁÖ¼¼¿ä

°£´ãÃé ¹× À̽Ŀܰú ºÐ¾ß¿¡ ¸ÅÁøÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ Àå±â À̽ÄÀº ÀÇÇÐ ±â¼úÀÇ ±Þ¼ÓÇÑ ¹ß´Þ°ú ´õºÒ¾î ´«ºÎ½Ã°Ô ¹ßÀüÇÏ´Â ºÐ¾ßÀ̸ç À̽ÄÀÇ È°¼ºÈ­¸¦ À§ÇÏ¿© ¿©·¯ ºÎ¼­¿¡¼­ ÇÔ²² ³ë·ÂÇϰí ÀÖ½À´Ï´Ù.
2008³â 2¿ù ±¹³» ÃÖÃÊ·Î ¼ºÀÎ ´ë»çÀå¾Ö ȯÀÚ¸¦ ´ë»óÀ¸·Î µ¿¼Ò¼º ºÎºÐ º¸Á¶ °£ÀÌ½Ä ¼ö¼ú(APOLT)¿¡ ¼º°øÇß½À´Ï´Ù. °£ Àüü¸¦ À̽ÄÇÏ´Â Åë»óÀûÀÎ ¹æ¹ý°ú ´Þ¸® ÀϺθ¸À» ¶¼¾î³»°í °°Àº ÀÚ¸®¿¡ ÇØ´ç ºÎÀ§¸¦ ºÎºÐ À̽ÄÇϴ ƯÀÌÇÑ ÄÉÀ̽º¿´½À´Ï´Ù. ¾Ï¸ð´Ï¾Æ¸¦ ÇØµ¶ÇÏ´Â È¿¼Ò°¡ °á¼ÕµÇ´Â ¿ä¼Òȸ·Î ÀÌ»óÁõ(Urea Cycle Disorder)À» ¾Î´Â ¼ºÀΠȯÀÚ¿´½À´Ï´Ù. ´ç½Ã±îÁö ±¹³»¿¡¼­ ÁøÇàµÈ µ¿¼Ò¼º ºÎºÐ º¸Á¶ °£ÀÌ½Ä ¼ö¼úÀº 4°Ç¹Û¿¡ ¾ø¾ú½À´Ï´Ù. ¼ºÀÎ ´ë»çÀå¾Ö ȯÀÚ¸¦ ´ë»óÀ¸·Î ÇÑ °æ¿ì´Â À̹øÀÌ ÃÖÃÊ¿´½À´Ï´Ù. ¼¼°èÀûÀ¸·Î µµ ¸¶Âù°¡ÁöÀÔ´Ï´Ù.

Q ȯÀÚ Áø·á¿¡ ÀÖ¾î °¡Àå Áß¿äÇÏ°Ô »ý°¢ÇÏ´Â °¡Ä¡´Â?

ÀÏ´Ü ¿Ü°úÀÇ»ç´Â ¼ö¼úÀ» ÀßÇØ¾ß ÇÑ´Ù°í »ý°¢ÇÕ´Ï´Ù. ¼ö¼úÀÌ ¿Ïº®ÇؾßÁÒ. ±×·¯¸é ³ª¸ÓÁö´Â ÀÚ¿¬½º·´°Ô µû¶ó¿ÀÁö ¾ÊÀ»±î¿ä. ¸ðµç ȯÀÚÀÇ ¿¹ÈÄ´Â ¼ö¼ú½Ç¿¡¼­ °áÁ¤µË´Ï´Ù. ¼ö¼úÀÌ ÀߵǸé ȯÀÚ°¡ ³ªºüÁú ÀÏÀÌ ¸¹Áö ¾Ê½À´Ï´Ù. ¼ö¼úÇÒ ¶§ ¹ÌÁøÇÑ ±¸¼®À» ³²±âÁö ¾Ê°í ¸ðµç °ÍÀ» ÇØ°áÇÏ·Á°í ÇÕ´Ï´Ù.

Q ȯÀڵ鿡°Ô ÀüÇÏ°í ½ÍÀº ¸»¾¸

¾ÏÀ» ºñ·ÔÇÑ ´Ù¾çÇÑ ÁúȯÀ¸·Î ¾î·Á¿î »óȲ¿¡ óÇÑ È¯Àڵ鿡°Ô Áø·á¿Í ¼ö¼úÀ» ÅëÇØ ¿ÏÄ¡¿¡ °¡±î¿î °á°ú¸¦ µå¸± ¶§ °¡Àå º¸¶÷À» ´À³§´Ï´Ù.
¿Ïº®ÇÑ ¼ö¼ú·Î ÇÕº´ÁõÀ» ÁÙÀ̰í ȯÀÚÀÇ »ýÁ¸À² Çâ»óÀ» À§ÇØ ÃÖ¼±À» ´ÙÇϰڽÀ´Ï´Ù.

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

°­µ¿°æÈñ´ëÇб³º´¿ø

Á¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
1577-5800
À¥»çÀÌÆ® ¾ÆÀÌÄÜȨÆäÀÌÁö

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

°­µ¿°æÈñ´ëÇб³º´¿øÀº Àǰú, ÇÑÀǰú, Ä¡°ú´ëÇÐÀ» ¸ðµÎ º¸À¯ÇÑ º´¿øÀ¸·Î, 3°³ ´ëÇк´¿øÀÇ ¼öÁØ ³ôÀº ÀÇ·á¼­ºñ½º¸¦ ÇÑ ¹ø¿¡ ¹ÞÀ» ¼ö ÀÖ´Ù. ¿¬¸éÀû 24,000¿© Æò º»°ü Áö»ó 14Ãþ, º°°ü Áö»ó 4ÃþÀÇ 800º´»óÀ» °®Ãè´Ù. ³úÁúȯ¡¤°üÀý¡¤Ã´Ãß µî Áúȯ Áß½ÉÀ¸·Î ƯȭµÈ ÇùÁø ÀÇ·á
¼­ºñ½º¸¦ Á¦°øÇÏ´Â ÀÇ¡¤ÇÑ ÇùÁø¼¾ÅÍ, ȯÀÚ ¼¼°è ÃÖ°í ¼öÁØÀÇ Áø·á½Ã½ºÅÛÀ» °®Ãá Àǰú
´ëÇк´¿ø, ÇÑÀÇÇÐÀ» ¼±µµÇÏ´Â ÇÑ¹æ ºê·£µåÆÄÀ§ 1À§ ÇÑÀǰú´ëÇк´¿ø¿Í Àü¹®¼º°ú ÆíÀǼºÀ» °®Ãá ȯÀÚ¸¸Á· º´¿øÀÎ Ä¡°ú´ëÇк´¿øÀÌ ÃÖ»óÀÇ ÀÇ·á¼­ºñ½º¸¦ Á¦°øÇϰí ÀÖ´Ù.

°­µ¿°æÈñ´ëÇб³º´¿ø À̹ÌÁö

¼­¿ïƯº°½Ã °­µ¿±¸ µ¿³²·Î 892

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä

°°Àº ºÐ¾ß ¸íÀÇ °°Àº ºÐ¾ß ¸íÀÇ

¸íÀÇ ´õº¸±â ´õº¸±â